ATX
Click for more information
1.64% 6.2¢ amplia therapeutics limited

Ann: Trading Halt, page-11

  1. itsagas
    13,075 Posts.
    lightbulb Created with Sketch. 1363
    clock Created with Sketch.
    23/06/17
    14:34
    Post #: 25455567
    Ngnz.
    Iil should have consulted the FDA re design study re P2b prior to the start.
    Since then Iil have been in touch with the FDA re design P3.
    Results due in August / Sept.but now to be released in June..
    Which tells me that the P2 b study should have had more patients and more clinical data..
    Just my opinion....hope I'm wrong.
    IIL Price at posting: 64.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.2¢ 		Change
0.001(1.64%) 		Mkt cap ! $16.83M
Open High Low Value Volume
6.1¢ 6.4¢ 6.1¢ $2.155K 35.07K

Buyers (Bids)

No. Vol. Price($)
1 59863 6.1¢
 

Sellers (Offers)

Price($) Vol. No.
6.2¢ 67722 1
View Market Depth
Last trade - 15.45pm 28/06/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.